Balss K M, Llanos G, Papandreou G, Maryanoff C A
Cordis Corporation, a Johnson & Johnson Company, Welsh and McKean Roads, Spring House, Pennsylvania 19477, USA.
J Biomed Mater Res A. 2008 Apr;85(1):258-70. doi: 10.1002/jbm.a.31535.
Raman spectroscopy was used to differentiate each component found in the CYPHER Sirolimus-eluting Coronary Stent. The unique spectral features identified for each component were then used to develop three separate calibration curves to describe the solid phase distribution found on drug-polymer coated stents. The calibration curves were obtained by analyzing confocal Raman spectral depth profiles from a set of 16 unique formulations of drug-polymer coatings sprayed onto stents and planar substrates. The sirolimus model was linear from 0 to 100 wt % of drug. The individual polymer calibration curves for poly(ethylene-co-vinyl acetate) [PEVA] and poly(n-butyl methacrylate) [PBMA] were also linear from 0 to 100 wt %. The calibration curves were tested on three independent drug-polymer coated stents. The sirolimus calibration predicted the drug content within 1 wt % of the laboratory assay value. The polymer calibrations predicted the content within 7 wt % of the formulation solution content. Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectra from five formulations confirmed a linear response to changes in sirolimus and polymer content.
拉曼光谱法被用于区分西罗莫司洗脱冠状动脉支架中发现的每种成分。然后,利用为每种成分确定的独特光谱特征,绘制出三条独立的校准曲线,以描述药物 - 聚合物涂层支架上的固相分布。校准曲线是通过分析共焦拉曼光谱深度分布获得的,这些分布来自喷覆在支架和平面基底上的16种独特药物 - 聚合物涂层配方。西罗莫司模型在药物含量从0至100 wt%范围内呈线性。聚(乙烯 - 共 - 醋酸乙烯酯)[PEVA]和聚(甲基丙烯酸正丁酯)[PBMA]的各聚合物校准曲线在0至100 wt%范围内也呈线性。校准曲线在三个独立的药物 - 聚合物涂层支架上进行了测试。西罗莫司校准预测的药物含量与实验室测定值相差在1 wt%以内。聚合物校准预测的含量与配方溶液含量相差在7 wt%以内。来自五种配方的衰减全反射傅里叶变换红外(ATR - FTIR)光谱证实了对西罗莫司和聚合物含量变化的线性响应。